Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc
- PMID: 18397957
- DOI: 10.1093/rheumatology/ken056
Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc
Abstract
Objective: To establish if IL-1 or TNF regulates matrix degradation in the non-degenerate or degenerate intervertebral disc (IVD).
Methods: In situ zymography (ISZ) has been used to investigate the role of IL-1 and TNF in the matrix degradation characterizing symptomatic IVD degeneration. ISZ employed three substrates (gelatin, collagen II, casein) and four different challenges, IL-1beta, IL-1 receptor antagonist (IL-1Ra), TNF-alpha and anti-TNF.
Results: We have shown for the first time that whilst IL-1beta will stimulate and IL-1 receptor antagonist will inhibit matrix degradation in intact human IVD tissue, neither TNF-alpha nor anti-TNF have any measurable effect on degradation of these matrices.
Conclusion: This study has addressed a current area of controversy in IVD biology, namely, whether either IL-1 or TNF or both are involved in driving matrix degradation. Our data indicate that IL-1 is a key cytokine mediating matrix degradation in the IVD and therefore a therapeutic target.
Similar articles
-
The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration.Arthritis Res Ther. 2005;7(4):R732-45. doi: 10.1186/ar1732. Epub 2005 Apr 1. Arthritis Res Ther. 2005. PMID: 15987475 Free PMC article.
-
Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study.Arthritis Res Ther. 2007;9(4):R83. doi: 10.1186/ar2282. Arthritis Res Ther. 2007. PMID: 17760968 Free PMC article.
-
Proinflammatory cytokines stimulate the expression of nerve growth factor by human intervertebral disc cells.Spine (Phila Pa 1976). 2007 Mar 15;32(6):635-42. doi: 10.1097/01.brs.0000257556.90850.53. Spine (Phila Pa 1976). 2007. PMID: 17413467
-
Programmed cell death in intervertebral disc degeneration.Apoptosis. 2006 Dec;11(12):2079-88. doi: 10.1007/s10495-006-0290-7. Apoptosis. 2006. PMID: 17051327 Review.
-
Current understanding of cellular and molecular events in intervertebral disc degeneration: implications for therapy.J Pathol. 2002 Apr;196(4):374-9. doi: 10.1002/path.1050. J Pathol. 2002. PMID: 11920731 Review.
Cited by
-
Class 3 semaphorins expression and association with innervation and angiogenesis within the degenerate human intervertebral disc.Oncotarget. 2015 Jul 30;6(21):18338-54. doi: 10.18632/oncotarget.4274. Oncotarget. 2015. PMID: 26286962 Free PMC article.
-
Nerves are more abundant than blood vessels in the degenerate human intervertebral disc.Arthritis Res Ther. 2015 Dec 21;17:370. doi: 10.1186/s13075-015-0889-6. Arthritis Res Ther. 2015. PMID: 26695177 Free PMC article.
-
PCRX-201, a novel IL-1Ra gene therapy treatment approach for low back pain resulting from intervertebral disc degeneration.Gene Ther. 2025 Mar;32(2):93-105. doi: 10.1038/s41434-024-00504-7. Epub 2024 Nov 21. Gene Ther. 2025. PMID: 39572769 Free PMC article.
-
Nucleus pulposus cell network modelling in the intervertebral disc.NPJ Syst Biol Appl. 2025 Jan 31;11(1):13. doi: 10.1038/s41540-024-00479-6. NPJ Syst Biol Appl. 2025. PMID: 39890859 Free PMC article.
-
Mesenchymal stromal/stem cells from perinatal sources: biological facts, molecular biomarkers, and therapeutic promises.Stem Cell Res Ther. 2025 Mar 7;16(1):127. doi: 10.1186/s13287-025-04254-0. Stem Cell Res Ther. 2025. PMID: 40055783 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical